Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: The Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01221402

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:28.365518+00:00

Published At

2017-08-17T00:00:00+00:00

Record Updated At

2017-08-17

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis", "Intermediate Saphenous Vein Graft Lesions"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-08-17"

protocolSection.identificationModule.nctId

"NCT01221402"

protocolSection.identificationModule.officialTitle

"Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: The Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis (protocolSection.conditionsModule.conditions)
• Intermediate Saphenous Vein Graft Lesions (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.